Screener
EBIT at other companies
Other financials
Where this comes from
Calculated from Bio-Rad Laboratories’s reported figures.
The source filing: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 30, 2026, 4:19 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000012208-26-000035
FAQ
- What is Bio-Rad Laboratories's EBIT?
- Bio-Rad Laboratories (BIO) reported EBIT of $34.1M in Q1 2026.
- How has Bio-Rad Laboratories's EBIT changed year-over-year?
- Bio-Rad Laboratories's EBIT increased by 43.9% year-over-year, from $23.7M to $34.1M.
- What is the long-term trend for Bio-Rad Laboratories's EBIT?
- Over 4 years (2021 to 2025), Bio-Rad Laboratories's EBIT has grown at a 22.0% compound annual growth rate (CAGR), from $500.34M to $1.11B.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Bio-Rad Laboratories's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude